Chest Physiotherapy in Infants Between 0 & 12 Months Old With Acute

Status Completed

Clinical Trial Summary

The purpose of this research is to determine the effect of prolonged slow expiration techniques, provoked coughing and standard therapy compared to chest wall manual vibration and standard therapy in infants between 0 and 12 months old with confirmed diagnosis of acute bronchiolitis SRV (+). The effect will be measured on respiratory insufficiency and use of supplementary oxygen.

Clinical Trial Description

Bronchiolitis is the main cause of hospital admission for infants under 1 year old in Chile. Currently, approximately 4800 children are admitted to the hospital during the cold season, affecting the health services' effectiveness. The most frequent causal agent is the Respiratory Syncytial Virus (RSV). To date, there is no specific treatment for this disease and only support measures are recommended.

Chest physiotherapy is a support measure that improves the mucociliary clearance and reduces obstruction of the airways.

A clinical trial on the effect of prolonged slow expiration (PSE), chest wall vibrations, and provoked coughing as treatment for bronchiolitis in infants admitted to the hospital found that the subgroup with RSV required oxygen for 10 hours less than the control group. Gomes and Postiaux (2012) reported a 50% decrease on respiratory distress measured by the Wang score when PSE and suction were compared to traditional chest physiotherapy techniques in patients with bronchiolitis RSV(+).

Currently recommendations in Chile suggest chest physiotherapy for outpatients with bronchiolitis, but the guideline does not refer to the case of inpatients. It is proposed to carry out a randomized controlled trial in infants under one year old. The active group will receive standard therapy, PSE, and provoked coughing, while the control group will receive standard therapy and manual chest wall vibrations. The effectiveness of chest physiotherapy will be measured though a clinical score of respiratory distress, hours using supplementary oxygen, vital signs before and after the intervention in both groups during hospital stay. The main outcome is clinical severity score 48 hours after admission. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02853838
Study type	Interventional
Source	Universidad del Desarrollo
Contact
Status	Completed
Phase	N/A
Start date	March 2015
Completion date	October 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04989114` - Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis	N/A
Recruiting	`NCT04287959` - SWISH Trial (Strategies for Weaning Infants on Supportive High Flow)	N/A
Not yet recruiting	`NCT01618175` - Home Oxygen Treatment of Childhood Acute Bronchiolitis	N/A
Completed	`NCT01247064` - Hypertonic Saline for Acute Bronchiolitis	Phase 4
Completed	`NCT03062917` - Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis	N/A
Recruiting	`NCT06030505` - Effectiveness of Nirsevimab in Children Hospitalised With RSV Bronchiolitis
Completed	`NCT02571517` - Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis	Phase 4
Terminated	`NCT03252119` - High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis	N/A
Active, not recruiting	`NCT04740294` - Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis	Phase 2/Phase 3
Terminated	`NCT03959384` - Efficacy and Safety of Curosurf® in Patients Invasively Ventilated for Severe Bronchiolitis Under 12 Months of Age	Phase 3
Completed	`NCT00119002` - The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis	Phase 4
Terminated	`NCT04221087` - Steroid Use in Non-RSV Bronchiolitis	Phase 4
Recruiting	`NCT04764929` - Pediatric Helmet CPAP Pilot Study	N/A
Completed	`NCT00122785` - Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms